- Home
- SILO vs AIMD Comparison
SILO vs AIMD Comparison
Compare SILO & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- AIMD
- Stock Information
- Founded
- SILO 2010
- AIMD 1984
- Country
- SILO United States
- AIMD United States
- Employees
- SILO N/A
- AIMD N/A
- Industry
- SILO Apparel
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- AIMD Health Care
- Exchange
- SILO Nasdaq
- AIMD Nasdaq
- Market Cap
- SILO 8.8M
- AIMD 7.5M
- IPO Year
- SILO N/A
- AIMD N/A
- Fundamental
- Price
- SILO $1.32
- AIMD $0.48
- Analyst Decision
- SILO
- AIMD
- Analyst Count
- SILO 0
- AIMD 0
- Target Price
- SILO N/A
- AIMD N/A
- AVG Volume (30 Days)
- SILO 116.2K
- AIMD 254.6K
- Earning Date
- SILO 03-18-2025
- AIMD 03-07-2025
- Dividend Yield
- SILO N/A
- AIMD N/A
- EPS Growth
- SILO N/A
- AIMD N/A
- EPS
- SILO N/A
- AIMD N/A
- Revenue
- SILO $72,102.00
- AIMD $20,729.00
- Revenue This Year
- SILO $1.86
- AIMD N/A
- Revenue Next Year
- SILO N/A
- AIMD N/A
- P/E Ratio
- SILO N/A
- AIMD N/A
- Revenue Growth
- SILO N/A
- AIMD N/A
- 52 Week Low
- SILO $0.77
- AIMD $0.40
- 52 Week High
- SILO $4.50
- AIMD $1.50
- Technical
- Relative Strength Index (RSI)
- SILO 45.03
- AIMD 38.30
- Support Level
- SILO $1.21
- AIMD $0.42
- Resistance Level
- SILO $1.34
- AIMD $0.50
- Average True Range (ATR)
- SILO 0.11
- AIMD 0.07
- MACD
- SILO 0.00
- AIMD -0.01
- Stochastic Oscillator
- SILO 41.38
- AIMD 24.56
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.